Rating History for Arcturus Therapeutics (ARCT) by B.Riley

More Stocks Rated by B.Riley | Latest Ratings for ARCT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/18/2026 Mayank Mamtani New Coverage Buy
(N/A)		 22.00
(N/A)		 6.63
(13.98)		 110.86% Details